Skip to main content

RA Capital Reports a $13 Million SPRY Buy

March 28, 2024

From the Desk of Steve Strazza and Alfonso Depablos

The most significant insider transaction on today’s list comes in a Form 4 filing by RA Capital Management.

The investment firm reported a purchase of $13.2 million in ARS Pharmaceuticals Inc $SPRY.

The CEO of Snowflake Inc $SNOW revealed a purchase of $5,000,037.

Here’s The Hot Corner, with data through March 27, 2024:

Avidity Partners filed a 13G for Jasper Therapeutics $JSPR revealing an initial stake of 5.10%.

The CEO and the CFO of Summit Therapeutics Inc $SMMT both filed Form 4s revealing a combined purchase worth $786,094.

Have a great long weekend. We'll be back on Monday with more insider activity.

Sign up for The Hot Corner to have these insider transactions e-mailed to you every Monday through Friday.

And please reach out with any questions. We love hearing from you!

All Star Charts Team